INTECH Investment Management’s Inozyme Pharma INZY Stock Holding History

INTECH Investment Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-32,892	Closed	-$132K	–	2454
2025 Q2	$132K	Sell	32,892 -6,835	-17%	-$16.9K	﹤0.01%	2219
2025 Q1	$36.2K	Buy	39,727 +15,140	+62%	+$21K	﹤0.01%	2461
2024 Q4	$68.1K	Buy	+24,587	New	+$93.5K	﹤0.01%	2284

INTECH Investment Management's INZY Position: Q3 2025 in Review

INTECH Investment Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 32,892 shares — an estimated $132K sold.

INTECH Investment Management first reported a position in INZY in Q4 2024 and held it in 3 quarters. The position peaked at $132K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

INTECH Investment Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
INTECH Investment Management sold 32,892 Inozyme Pharma shares in Q3 2025, an estimated $132K.
INTECH Investment Management first reported a position in Inozyme Pharma in Q4 2024 and held it in 3 quarters.
INTECH Investment Management's Inozyme Pharma position peaked at $132K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on INTECH Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.